Pharmacists in Wilkes Barre, Pennsylvania


237 Pharmacists found in Wilkes Barre
female pharmacist

Teressa Ann Polinsky, PHARM.D.


Pharmacist
53 Gravel St, Wilkes Barre, PA 18705
570-970-2200    

female pharmacist

Terrah Adams, PHARMD


Pharmacist
245 Wilkes Barre Township Blvd, Wilkes Barre, PA 18702
570-825-3037    

female pharmacist

Theresa Charnetski


Pharmacist
33 Public Sq, Wilkes Barre, PA 18701
570-825-9481    



male pharmacist

Dr. Thomas Stephen Franko Ii, PHARMD


Pharmacist
84 W South St, Wilkes Barre, PA 18766
570-408-4295    

female pharmacist

Tiffany Babcock, PHARMD


Pharmacist
58 Public Sq, Wilkes Barre, PA 18701
570-284-3756    

female pharmacist

Trina Patel


Pharmacist
1111 E End Blvd, Wilkes Barre, PA 18711
570-824-3521    

female pharmacist

Troy Lynn Lewis, PHARMD


Pharmacist
84 W South St, Wilkes Barre, PA 18701
570-408-4977    

male pharmacist

Dr. Tyler William Young


Pharmacist
1111 E End Blvd, Wilkes Barre, PA 18711
570-824-3521    

female pharmacist

Vanessa Anne Markle, PHARMACIST


Pharmacist
1000 E Mountain Blvd, Wilkes Barre, PA 18711
570-808-7754    

male pharmacist

Dr. Vicky Shah, PHARMD, BCPS


Pharmacist - Pharmacotherapy
1111 E End Blvd, Wilkes Barre, PA 18711
847-826-0834    

male pharmacist

Dr. Walter Mieczkowski Iii


Pharmacist
1000 E Mountain Blvd, Wilkes Barre, PA 18711
570-808-7300    

male pharmacist

William F King


Pharmacist
1111 E End Blvd, Wilkes Barre, PA 18711
570-824-3521    

male pharmacist

Zachary Connor Schmidt, PHARMD


Pharmacist
25 Church St Fl 4, Wilkes Barre, PA 18765
570-208-4721    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.